Centres of Excellence
Specialised, multidisciplinary centres delivering world-class clinical outcomes across every major speciality.
Trauma & Critical Care Centre
The Trauma & Critical Care Centre at SilverOak Health is a major trauma centre providing 24/7 specialist care for patients with life-threatening injuries and critical illness, supported by a dedicated multidisciplinary team of trauma surgeons, emergency physicians, intensivists, anaesthesiologists, orthopaedic surgeons, neurosurgeons, and specialist nursing staff. Our trauma programme delivers coordinated, protocol-driven care from the scene of injury through definitive surgical management, critical care, and rehabilitation. Trauma team activation for major injuries triggers simultaneous preparation of the resuscitation bay, trauma surgical team, operating theatres, and intensive care unit. Primary survey and damage control resuscitation using balanced haemostatic resuscitation — combining packed red blood cells, fresh frozen plasma, and platelets in a 1:1:1 ratio — begins in the emergency department and continues through the operating theatre for haemodynamically unstable patients. Massive transfusion protocols activated by our haematology and blood bank team ensure rapid availability of blood products around the clock. Damage control surgery — abbreviated initial procedures to control haemorrhage and contamination, followed by planned definitive repair after physiological resuscitation — is the operative strategy for the most critically injured patients. Temporary vascular shunting for vascular injuries, perihepatic packing for liver trauma, and external fixation of unstable pelvic fractures are key initial damage control manoeuvres. Interventional radiology — available 24 hours — provides transcatheter embolisation for vascular bleeding from solid organ, pelvic, and bronchial sources, achieving haemostasis without surgical exploration in many cases. Our intensive care unit provides the highest level of organ support for critically ill patients — whether from trauma, sepsis, post-cardiac arrest, or post-major surgery. Advanced monitoring including arterial lines, central venous and pulmonary artery catheters, intracranial pressure monitoring, and continuous EEG guides therapy. Mechanical ventilation using lung-protective strategies, renal replacement therapy for acute kidney injury, vasopressor and inotropic support, and targeted temperature management after cardiac arrest are all delivered within our evidence-based critical care protocols. Rehabilitation within the critical care environment — including early mobilisation by our ICU physiotherapy and occupational therapy team, nutritional support optimised by critical care dietitians, and psychological support for patients and families — mitigates the physical deconditioning and cognitive sequelae of critical illness. Post-intensive care syndrome follow-up clinic supports patients recovering from prolonged ICU admission. Our trauma and critical care programme participates in national major trauma audit (TARN), enabling continuous benchmarking of survival rates and functional outcomes against comparable centres nationally.
Explore →Rheumatology & Autoimmune Diseases Centre
The Rheumatology & Autoimmune Diseases Centre at SilverOak Health provides specialist assessment and management of inflammatory arthropathies, systemic autoimmune diseases, crystal arthropathies, and musculoskeletal conditions. Our consultant rheumatologists bring deep expertise in the rapidly evolving landscape of biologic and targeted synthetic disease-modifying therapies, delivering care that achieves disease remission and prevents the irreversible joint damage and organ involvement that characterise undertreated inflammatory disease. Early and accurate diagnosis is the cornerstone of effective rheumatological care — our rapid access clinic provides urgent assessment within two weeks for suspected new inflammatory arthritis, ensuring treatment is initiated before irreversible joint damage accrues. Conditions managed include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis, systemic lupus erythematosus, Sjögren's syndrome, inflammatory myositis, systemic sclerosis, ANCA-associated vasculitis, giant cell arteritis, polymyalgia rheumatica, antiphospholipid syndrome, gout, pseudogout, and reactive arthritis. Treatment protocols follow EULAR and NICE recommendations, utilising conventional DMARDs — methotrexate, hydroxychloroquine, leflunomide, and sulfasalazine — as first-line therapy. For patients with inadequate responses, biologic DMARDs — anti-TNF agents, anti-IL-6 (tocilizumab, sarilumab), anti-IL-17 (secukinumab, ixekizumab), anti-IL-23 (guselkumab, risankizumab), rituximab, and abatacept — and targeted synthetic DMARDs including JAK inhibitors (baricitinib, upadacitinib, filgotinib) are offered according to disease type and comorbidity profile. Our biologic therapy clinic monitors treatment safety and efficacy with systematic recording of disease activity scores, patient-reported outcome measures, laboratory parameters, and infection surveillance. Specialist rheumatology nurses provide education, injection training, telephone support between appointments, and proactive monitoring to maximise medication adherence and early identification of adverse effects. Musculoskeletal ultrasound — used for assessment of joint and soft tissue inflammation and for guided injection of joints, tendons, and bursae — is performed in clinic by our trained rheumatologists. Multidisciplinary management with physiotherapy, occupational therapy, podiatry, and psychology is integral to our rheumatology programme, addressing the functional, work-related, and psychological consequences of chronic inflammatory disease. Bone densitometry and fracture risk assessment with FRAX guide osteoporosis prevention and treatment in patients receiving glucocorticoids or at elevated risk. Our specialist connective tissue disease service — managing lupus, scleroderma, myositis, and vasculitis — collaborates with nephrology, respiratory medicine, cardiology, and dermatology for the multisystem complications of these complex conditions.
Explore →Gastroenterology & Hepatology Centre
The Gastroenterology & Hepatology Centre at SilverOak Health provides comprehensive diagnostic and therapeutic services for conditions affecting the oesophagus, stomach, small intestine, colon, liver, pancreas, and biliary tract. Our consultant gastroenterologists and hepatologists hold subspecialty interests in inflammatory bowel disease, advanced endoscopy, liver disease, gastrointestinal oncology, and functional gastrointestinal disorders, delivering care that integrates the most current evidence with individualised patient management. Endoscopy services encompass upper GI endoscopy, colonoscopy, flexible sigmoidoscopy, and capsule endoscopy for small bowel imaging. Our therapeutic endoscopy programme includes polypectomy using cold snare and hot snare techniques, endoscopic mucosal resection and endoscopic submucosal dissection for large polyps and early cancers, variceal band ligation and cyanoacrylate injection for portal hypertension complications, oesophageal and colonic stenting, and ERCP with sphincterotomy, biliary stenting, and stone extraction for biliary and pancreatic duct pathology. Inflammatory bowel disease — Crohn's disease and ulcerative colitis — is managed within a dedicated IBD service providing biological therapy initiation and monitoring, therapeutic drug monitoring to optimise anti-TNF and anti-integrin drug levels, small bowel imaging with MRI enterography, and close collaboration with colorectal surgery and IBD specialist nurses for flare management and surgical planning. Our IBD service participates in national audit and quality improvement programmes to benchmark outcomes and patient experience. Hepatology services address all forms of chronic liver disease. Viral hepatitis B and C — now potentially curable with modern direct-acting antiviral regimens — are managed with the most up-to-date treatment protocols. Non-alcoholic steatohepatitis, alcoholic hepatitis, autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, Wilson's disease, and haemochromatosis are all managed in specialist hepatology clinics. Non-invasive liver fibrosis assessment using Fibroscan elastography and serum biomarkers guides surveillance intensity and treatment decisions. Our multidisciplinary liver MDT coordinates management of cirrhosis complications — ascites, hepatic encephalopathy, variceal bleeding, and hepatorenal syndrome — hepatocellular carcinoma surveillance and treatment using ablation, TACE, SIRT, and systemic therapy, and transplant referral for end-stage liver disease. Interventional radiology — TIPSS for refractory ascites and refractory variceal bleeding — is available within our hepatology programme. Nutritional assessment and dietetic support are integral to all hepatology and IBD patient management.
Explore →Pulmonology & Respiratory Medicine Centre
The Pulmonology & Respiratory Medicine Centre at SilverOak Health provides expert management of acute and chronic lung conditions, using advanced diagnostic technology and evidence-based treatment protocols to optimise respiratory function and quality of life. Our consultant respiratory physicians hold subspecialty interests in obstructive lung disease, interstitial lung disease, pulmonary hypertension, respiratory oncology, pleural disease, interventional pulmonology, and sleep-disordered breathing. Diagnostic capabilities include comprehensive pulmonary function testing encompassing spirometry, lung volumes by body plethysmography, diffusing capacity (DLCO), bronchoprovocation testing for asthma diagnosis, and six-minute walk test. Bronchoscopy services include standard flexible bronchoscopy with BAL and transbronchial biopsy, endobronchial ultrasound (EBUS) for mediastinal lymph node staging and sampling, electromagnetic navigation bronchoscopy for peripheral lung lesion access, and cryobiopsy for interstitial lung disease diagnosis — achieving diagnostic yields superior to conventional forceps biopsy. COPD management integrates optimised inhaler therapy with spirometry-guided stepping, pulmonary rehabilitation — our 12-week structured programme improving exercise capacity and reducing exacerbation frequency — smoking cessation pharmacotherapy, nutritional optimisation, and early supported discharge for exacerbations. Our interstitial lung disease clinic provides diagnosis and management of IPF, non-specific interstitial pneumonia, hypersensitivity pneumonitis, connective tissue disease-related ILD, and sarcoidosis, initiating antifibrotic therapy (nintedanib, pirfenidone) for progressive fibrotic ILD according to current ATS/ERS guidelines. Pleural services include diagnostic and therapeutic ultrasound-guided pleural aspiration, medical pleuroscopy (local anaesthetic thoracoscopy) for undiagnosed pleural effusions and pleural biopsy, indwelling pleural catheter insertion for recurrent malignant effusions, and chemical pleurodesis for pneumothorax and malignant effusion. Our thoracic MDT meets weekly, bringing together respiratory physicians, thoracic surgeons, radiologists, and oncologists to plan management for lung cancer and complex thoracic cases. Pulmonary hypertension — managed within a specialist clinic in close collaboration with cardiology — encompasses assessment by right heart catheterisation, initiation and monitoring of pulmonary arterial hypertension-targeted vasodilator therapy, and co-management of left heart disease and chronic thromboembolic pulmonary hypertension. Asthma management at every severity level, obesity hypoventilation syndrome, sleep apnoea assessment and CPAP/NIV titration, and management of ventilated patients requiring long-term non-invasive respiratory support complete our comprehensive respiratory service.
Explore →Diabetes & Endocrinology Centre
The Diabetes & Endocrinology Centre at SilverOak Health provides expert assessment and management of the full spectrum of hormonal disorders and metabolic diseases, combining evidence-based clinical practice with an active research programme that ensures our patients have access to the most current therapeutic options. Our consultant endocrinologists and specialist diabetes nurses deliver care that is patient-centred, holistic, and focused on empowering individuals to optimise their own health. Type 1 and type 2 diabetes mellitus management at our centre encompasses structured patient education programmes — DESMOND for type 2 and DAFNE for type 1 — continuous glucose monitoring interpretation clinics using flash and real-time CGM systems, insulin pump therapy initiation and optimisation for type 1 and selected insulin-requiring type 2 patients, and management of complex diabetes complications in dedicated multidisciplinary clinics. Our diabetic foot clinic brings together endocrinologists, vascular surgeons, podiatrists, orthopaedic surgeons, and wound care nurses to manage the most common cause of non-traumatic lower limb amputation. Thyroid disease is among our most common referral diagnoses. Hypothyroidism and hyperthyroidism management, thyroid nodule evaluation with ultrasound and fine-needle aspiration cytology, radioiodine therapy for Graves' disease and toxic nodular goitre, and thyroid cancer management in collaboration with our oncology team are all provided within our integrated thyroid service. Adrenal diseases managed include Cushing's syndrome from all causes, primary hyperaldosteronism, phaeochromocytoma and paraganglioma, adrenal incidentaloma, and primary and secondary adrenal insufficiency. Pituitary diseases — acromegaly, prolactinoma, Cushing's disease, non-functioning pituitary adenomas, craniopharyngioma, and hypopituitarism — are managed within our dedicated pituitary MDT meeting monthly with neurosurgery and radiation oncology. Dynamic endocrine function testing — synacthen, insulin stress, oral glucose tolerance, water deprivation, and glucagon stimulation tests — is performed in our dedicated endocrine investigation unit with experienced nursing supervision. Metabolic bone disease including osteoporosis, hypercalcaemia, hypoparathyroidism, and Paget's disease of bone is managed with modern antiresorptive and osteoanabolic therapies. Obesity medicine — encompassing structured lifestyle intervention, pharmacological treatment with GLP-1 receptor agonists and dual GLP-1/GIP agonists, and pre- and post-bariatric surgery metabolic optimisation — is a growing component of our service given the central role of obesity in type 2 diabetes, cardiovascular disease, and fatty liver disease. Neuroendocrine tumours, disorders of puberty, polycystic ovary syndrome, and male hypogonadism complete the breadth of conditions managed within our endocrinology programme. Close collaboration with dietetics, psychology, and physiotherapy ensures truly holistic metabolic care.
Explore →Paediatric Medicine & Surgery Centre
The Paediatric Medicine & Surgery Centre at SilverOak Health provides comprehensive inpatient and outpatient care for children from the newborn period through adolescence, managed by a dedicated paediatric team that understands the unique physiological, developmental, and emotional needs of children and their families. Our consultant paediatricians, paediatric surgeons, paediatric anaesthesiologists, and paediatric specialist nurses deliver care in a child-friendly environment designed to minimise distress and support family involvement at every step. General paediatric medicine encompasses the assessment and management of acute childhood illnesses — respiratory infections, febrile illness, gastroenteritis, urinary tract infections, and seizures — alongside chronic condition management for asthma, eczema, diabetes, epilepsy, inflammatory bowel disease, and coeliac disease. Our paediatric emergency pathway provides rapid assessment and treatment for children presenting with acute illness, with paediatricians available around the clock to manage life-threatening conditions including anaphylaxis, status epilepticus, and sepsis. Neonatal services provide expert care for newborns requiring medical attention — including prematurity, respiratory distress syndrome, neonatal jaundice, neonatal infections, and congenital anomalies identified antenatally. Our neonatologists work closely with our maternal-foetal medicine team to ensure seamless transition of care for high-risk pregnancies. Newborn hearing screening, metabolic screening, and developmental surveillance are integrated into our postnatal care pathway. Paediatric surgery at our centre addresses congenital anomalies including pyloric stenosis, intussusception, malrotation with volvulus, inguinal hernia, and undescended testis, as well as acquired conditions including appendicitis, adhesive bowel obstruction, and trauma. Minimally invasive surgical approaches — laparoscopic appendicectomy, laparoscopic Nissen fundoplication, and thoracoscopic procedures — are standard for appropriate cases, minimising surgical trauma and accelerating recovery in children. Paediatric subspecialty services — including paediatric neurology, paediatric cardiology, paediatric endocrinology, paediatric rheumatology, paediatric nephrology, and paediatric haematology — are available through our integrated multidisciplinary programme, ensuring children with complex multisystem conditions receive coordinated care from all relevant subspecialties. Child protection evaluation and safeguarding support is embedded within our paediatric service. Our family-centred care model keeps parents and carers fully informed and actively involved in every aspect of their child's care.
Explore →Minimally Invasive Gynaecological Surgery Centre
The Minimally Invasive Gynaecological Surgery Centre at SilverOak Health is led by advanced laparoscopic surgeons with subspecialty expertise in complex benign gynaecological conditions, offering the full range of laparoscopic and hysteroscopic procedures that enable effective surgical treatment with dramatically reduced recovery compared to traditional open approaches. Our programme is a recognised referral centre for complex endometriosis, fibroid surgery, and pelvic floor disorders. Laparoscopic procedures performed at our centre include total laparoscopic hysterectomy — our highest-volume procedure — laparoscopic myomectomy for fibroid removal with uterine preservation, laparoscopic ovarian cystectomy and oophorectomy, salpingostomy and salpingectomy for ectopic pregnancy, laparoscopic treatment of pelvic inflammatory disease complications, and laparoscopic sacrocolpopexy for pelvic organ prolapse. Robotic-assisted approaches are available for complex cases where additional instrument dexterity and three-dimensional visualisation improve safety and precision. Endometriosis surgery is a particular expertise of our programme. Deep infiltrating endometriosis involving the bowel, bladder, ureters, ovaries, and pelvic peritoneum demands a dedicated multidisciplinary team — our gynaecological endometriosis surgeons work alongside colorectal surgeons, urologists, and pain management specialists for the most complex resections. Excision of all visible endometriosis — including bowel resection when required — rather than ablation or fulguration achieves superior pain relief, lower recurrence rates, and improved fertility outcomes. Hysteroscopic procedures — performed entirely through the cervical canal without abdominal incisions — encompass endometrial polypectomy, submucosal fibroid resection with bipolar energy, Asherman's syndrome lysis of intrauterine adhesions, uterine septum division, and global endometrial ablation for heavy menstrual bleeding refractory to medical management. Office hysteroscopy under local anaesthesia is offered for diagnostic and simple operative procedures, significantly reducing patient inconvenience and NHS waiting times. Our laparoscopic skill extends to oncological procedures — staging surgery for endometrial cancer, laparoscopic trachelectomy for cervical cancer with fertility preservation, and laparoscopic management of borderline ovarian tumours. Fertility-sparing approaches are prioritised for women of reproductive age, with careful counselling regarding the balance between completeness of surgery and future fertility potential. Post-operative enhanced recovery pathways with same-day or next-day discharge for the majority of laparoscopic procedures ensure rapid return to normal activities.
Explore →Fertility & Reproductive Medicine Centre
The Fertility & Reproductive Medicine Centre at SilverOak Health offers comprehensive evaluation and treatment for individuals and couples experiencing infertility, recurrent pregnancy loss, or seeking fertility preservation. Our reproductive endocrinologists, embryologists, and fertility nurses combine the most advanced assisted reproductive technology with compassionate, individualised care that acknowledges the profound emotional journey of fertility treatment. Initial fertility assessment is comprehensive, addressing both partners simultaneously. Female assessment encompasses hormonal profiling (FSH, LH, AMH, oestradiol), antral follicle count, hysterosalpingography or sonohysterography for uterine cavity and tubal evaluation, diagnostic hysteroscopy and laparoscopy when indicated, and thrombophilia and immunological screening for recurrent miscarriage. Male assessment includes full semen analysis with morphology, concentration, and motility, DNA fragmentation testing for unexplained infertility, and hormonal evaluation and andrology review for azoospermia. Our IVF programme employs individualised ovarian stimulation protocols — GnRH agonist long protocols, antagonist protocols, and progestin-primed variants — adapted to each patient's age, ovarian reserve, and prior treatment response. Time-lapse embryo monitoring in our state-of-the-art embryology laboratory provides continuous assessment of embryo development kinetics without disturbance, informing morphokinetic selection of the highest-quality blastocyst for transfer. Endometrial receptivity testing optimises the window of implantation for personalised frozen embryo transfer timing. Preimplantation genetic testing — PGT-A for chromosomal aneuploidy screening and PGT-M for single gene disorders — is offered to couples at risk of transmitting heritable conditions or with a history of recurrent implantation failure or miscarriage. Our programme achieves clinical pregnancy rates per embryo transfer consistently above HFEA national benchmarks. Fertility preservation — egg vitrification, embryo freezing, and ovarian tissue cryopreservation — is offered for medical indications including oncology patients facing gonadotoxic treatment and for elective social egg freezing. Recurrent pregnancy loss investigations follow NICE and ESHRE guidelines, with targeted treatment for identified causes including antiphospholipid syndrome, uterine anomalies, parental chromosomal factors, and thrombophilias. Donor egg, donor sperm, and surrogacy pathways are available for patients who cannot use their own gametes. Holistic psychological support — individual counselling, group therapy, and mindfulness programmes — is integral to our fertility service, recognising the significant emotional burden of infertility and treatment failure on patients and their partners.
Explore →Maternal-Foetal Medicine Centre
The Maternal-Foetal Medicine Centre at SilverOak Health provides subspecialty obstetric care for pregnancies at increased risk due to maternal medical conditions, previous obstetric complications, or identified foetal abnormalities. Our maternal-foetal medicine specialists work within the obstetric team, collaborating closely with cardiologists, nephrologists, haematologists, endocrinologists, and neonatologists to provide truly integrated multidisciplinary management for every complex pregnancy. Maternal conditions managed within our programme include pre-existing diabetes with vascular complications, cardiac disease in pregnancy (congenital and acquired), chronic kidney disease and renal transplant pregnancies, autoimmune conditions including systemic lupus erythematosus and antiphospholipid syndrome, haematological disorders such as sickle cell disease and inherited thrombophilias, chronic hypertension, inflammatory bowel disease, epilepsy, and psychiatric conditions requiring medication management during pregnancy. Pre-conception counselling is offered to women with medical conditions who are planning pregnancy, enabling optimisation of disease control and medication review before conception to minimise teratogenic risk and maximise maternal and foetal safety. Detailed booking assessments for all high-risk pregnancies establish risk-stratified surveillance plans with personalised monitoring schedules and clear escalation thresholds. Pre-eclampsia prediction using first trimester combined screening (MAP, uterine artery Doppler, PLGF) with aspirin prophylaxis for high-risk cases reduces preterm pre-eclampsia by 62%. Foetal medicine services include detailed anomaly scanning, foetal echocardiography for cardiac defect evaluation, growth and Doppler surveillance for intrauterine growth restriction, amniotic fluid assessment, and invasive testing — amniocentesis and chorionic villus sampling — with a procedural complication rate below 0.5%. In utero therapeutic interventions — laser therapy for twin-to-twin transfusion syndrome using selective fetoscopic laser coagulation, foetal thoracocentesis for pleural effusions, foetal blood transfusion for severe anaemia, and selective foetal reduction in higher-order pregnancies — are performed by our most experienced subspecialists. Our multidisciplinary foetal anomaly MDT meets weekly, bringing together MFM specialists, paediatric surgeons, neonatologists, clinical geneticists, paediatric cardiologists, and neurosurgeons to provide comprehensive, honest counselling and individualised delivery and neonatal management planning for families facing significant prenatal diagnoses. Bereavement support and clinical psychology are integral to our care for families receiving difficult news. Our neonatal intensive care unit provides immediate expert care for premature and sick newborns born within our maternity service.
Explore →Urological Sciences Centre
The Urological Sciences Centre at SilverOak Health provides comprehensive surgical and medical management of conditions affecting the urinary tract and male reproductive system, from common conditions such as benign prostatic hyperplasia and kidney stones through complex urological malignancies requiring robotic-assisted surgical resection. Our consultant urologists are fellowship-trained in urological oncology, endourology, functional urology, and reconstructive urology. Urological oncology is a primary focus, with robotic-assisted prostatectomy, partial and radical nephrectomy, radical cystectomy with urinary diversion (ileal conduit or orthotopic neobladder), and testicular cancer surgery performed by subspecialty-trained oncological urologists within our urological cancer MDT. Our PSMA PET-CT programme enables highly sensitive detection of recurrent prostate cancer at PSA levels below 0.5 ng/mL, guiding salvage therapy decisions. Lutetium-PSMA radioligand therapy for metastatic castration-resistant prostate cancer is available within our theranostics programme. Stone disease management encompasses flexible ureteroscopy with holmium laser lithotripsy for ureteric and renal calculi, percutaneous nephrolithotomy for large or staghorn renal stones, and extracorporeal shockwave lithotripsy. Metabolic stone evaluation identifies urinary risk factors — hypercalciuria, hyperoxaluria, hypocitraturia, and hyperuricosuria — and guides dietary and pharmacological prevention strategies to reduce the high recurrence rate of urolithiasis. Our stone service operates a 24-hour emergency pathway for obstructing stones and sepsis. Functional urology services address benign prostatic hyperplasia with a range of treatment options from medical therapy through office-based minimally invasive procedures (Rezūm water vapour therapy, UroLift prostatic urethral lift) and surgical options including HoLEP laser enucleation and TURP. Overactive bladder, stress urinary incontinence, interstitial cystitis, neurogenic bladder, and male incontinence after prostatectomy are managed within dedicated functional urology clinics with conservative, medical, and surgical pathways. Reconstructive urology — including urethral stricture management with endoscopy and urethroplasty, artificial urinary sphincter implantation, male and female slings, and complex revision procedures — is offered by our reconstructive subspecialist. Erectile dysfunction evaluation and treatment (PDE5 inhibitors, vacuum devices, intracavernosal injection, and penile prosthesis implantation) and Peyronie's disease management complete our andrological services. Urogynaecological collaboration ensures seamless management of female pelvic floor disorders requiring joint urological and gynaecological expertise.
Explore →Advanced Dialysis & Chronic Kidney Disease Centre
The Advanced Dialysis & Chronic Kidney Disease Centre at SilverOak Health provides comprehensive care for patients across all stages of CKD — from early detection and slowing of disease progression through preparation for renal replacement therapy and long-term dialysis management. Our consultant nephrologists, specialist nurses, renal dietitians, and social workers work collaboratively within a structured programme that optimises medical management, delays progression, and empowers patients to make informed choices about their future care. Early CKD management focuses on targeted treatment of underlying causes — immunosuppression for glomerular diseases, optimised blood pressure control, RAAS blockade, SGLT2 inhibition, and stringent cardiovascular risk reduction — to preserve residual kidney function for as long as possible. Regular monitoring of GFR trajectory, proteinuria, anaemia, CKD-mineral bone disorder, and acidosis enables timely intervention before complications develop. Our pre-dialysis education programme introduces all modality options — haemodialysis, peritoneal dialysis, and transplantation — well in advance of end-stage disease. In-centre haemodialysis is delivered three times weekly in our purpose-designed unit operating across morning, afternoon, and evening shifts. Haemodiafiltration — offering enhanced clearance of medium-molecular-weight uraemic toxins — is available for patients who tolerate high-volume convective therapies. Arteriovenous fistula creation and maintenance using minimally invasive surgical and endovascular techniques is managed by our dedicated vascular access team, achieving first-use fistula rates consistently above national standards. Home dialysis programmes — including automated peritoneal dialysis, continuous ambulatory peritoneal dialysis, and home haemodialysis — are supported by comprehensive training over two to three weeks, regular home visits, and 24-hour specialist nursing telephone access. Home dialysis offers superior lifestyle flexibility, preservation of residual renal function, and equivalent or better survival compared to in-centre haemodialysis in appropriately selected patients. Our home dialysis penetration rates exceed national averages, reflecting our commitment to patient-centred modality choice. Acute kidney injury management, including continuous renal replacement therapy for critically ill patients in our ICU, and management of resistant hypertension, fluid-refractory heart failure with ultrafiltration, and complex electrolyte disorders complete our renal medicine offering. Multidisciplinary care with cardiology, diabetes medicine, haematology, and infectious disease ensures that the systemic manifestations of advanced renal disease are managed comprehensively alongside kidney-directed interventions.
Explore →Kidney Transplant Centre
The Kidney Transplant Centre at SilverOak Health is a comprehensive renal transplantation programme offering living donor and deceased donor kidney transplantation, supported by a multidisciplinary team of transplant nephrologists, transplant surgeons, transplant coordinators, immunologists, and specialist nurses dedicated to delivering the best possible outcomes for patients with end-stage kidney disease. Kidney transplantation provides superior survival, quality of life, and freedom from dialysis compared to any form of renal replacement therapy. Pre-emptive transplantation — performed before dialysis initiation — offers the best outcomes and is actively pursued for suitable living donor pairs. Our pre-transplant evaluation programme comprehensively assesses recipient fitness, immunological compatibility through HLA typing and crossmatch testing, cardiovascular readiness, and freedom from active infection or malignancy that would contraindicate immunosuppression. Living donor evaluation prioritises donor safety above all other considerations. Laparoscopic donor nephrectomy — standard in our programme — minimises the surgical burden on donors, enabling same-day or next-day mobilisation and discharge within two to three days. ABO-incompatible living donor transplantation using desensitisation protocols expands the living donor pool for recipients with blood group barriers. Paired kidney exchange programmes are available to enable living donor transplants when direct immunological compatibility precludes direct donation. Deceased donor transplantation — including standard criteria, expanded criteria, and donation after circulatory death kidneys — is performed through our 24/7 on-call transplant programme. Machine perfusion of donor kidneys — both hypothermic and normothermic — is used for marginal donor organs to assess viability and reduce delayed graft function rates. Our allocation protocols prioritise sensitised recipients, paediatric candidates, and long-waiting patients in accordance with national guidelines. Post-transplant immunosuppression with tacrolimus, mycophenolate, and prednisolone is individualised based on immunological risk, donor-specific antibody status, and graft function. Surveillance biopsy at three and twelve months detects subclinical rejection and enables early treatment before overt dysfunction occurs. Monitoring for opportunistic infections, BK virus nephropathy, malignancy, and cardiovascular disease is structured and protocol-driven. Our one-year graft survival rates consistently exceed 95% for living donor and 90% for deceased donor transplants.
Explore →Spine & Disc Centre
The Spine & Disc Centre at SilverOak Health provides comprehensive surgical and non-surgical management of the full spectrum of spinal conditions — from common disc herniations and degenerative disease to complex deformities, tumours, and trauma. Our spine surgeons hold dual orthopaedic and neurosurgical training, enabling a comprehensive operative armamentarium for the most complex cases, and work within a multidisciplinary spine team that ensures surgery is recommended only after all appropriate conservative treatments have been explored. Minimally invasive spine surgery is the standard of care for appropriate cases at our centre. Tubular microdiscectomy for lumbar disc herniation, endoscopic discectomy, minimally invasive TLIF and PLIF for lumbar fusion, percutaneous pedicle screw fixation, and lateral lumbar interbody fusion through the retroperitoneal corridor dramatically reduce muscle damage, blood loss, and post-operative pain compared to conventional open approaches, translating into faster recovery and earlier return to work and activity. Navigation-assisted and robotic-guided implant placement — using intraoperative CT-based navigation that updates in real time with patient movement — ensures sub-millimetre pedicle screw accuracy. This is particularly critical in complex deformity correction, revision surgery, and osteoporotic spine where implant malposition risks neurological injury or fixation failure. Three-dimensional intraoperative imaging provides immediate post-implantation confirmation of screw position before wound closure. Cervical spine surgery — including anterior cervical discectomy and fusion, cervical artificial disc replacement, and posterior laminoplasty and laminectomy — addresses cervical radiculopathy and myelopathy with the goal of neural decompression and functional restoration. Adjacent segment disease after prior fusion, spinal instability, and stenosis with myelopathy requiring multilevel decompression and stabilisation are managed with staged planning and intraoperative neurophysiology monitoring. Complex spinal deformity correction for adult de novo and degenerative scoliosis, kyphosis, and flatback deformity requires extensive pre-operative planning — including three-dimensional radiographic analysis, sagittal balance assessment, and simulation of proposed correction — to achieve optimal spinal alignment with acceptable surgical risk. Our spinal deformity programme collaborates with pain medicine, respiratory medicine, and geriatrics for optimising pre-operative status in frail patients. Spinal tumour resection, vertebroplasty and kyphoplasty for osteoporotic fractures, and spine trauma surgery complete our comprehensive spinal offering.
Explore →Paediatric Orthopaedics & Scoliosis Centre
The Paediatric Orthopaedics & Scoliosis Centre at SilverOak Health provides specialist musculoskeletal care for children from infancy through skeletal maturity, addressing congenital, developmental, and acquired orthopaedic conditions that require expertise specific to the growing skeleton. Our paediatric orthopaedic surgeons, paediatric anaesthesiologists, and specialist nurses create a child-friendly environment in which families feel confident and supported throughout diagnosis, treatment, and recovery. Scoliosis management is a core focus of our programme. Adolescent idiopathic scoliosis — the most common spinal deformity in children — is managed with observation for mild curves, Rigo Chêneau or Boston brace treatment for curves in the bracing range, and posterior spinal fusion with pedicle screw instrumentation for progressive curves exceeding surgical thresholds. Neuromuscular scoliosis, congenital scoliosis, and early-onset scoliosis requiring growing rod constructs or vertebral body tethering are managed with the multidisciplinary expertise these complex conditions demand. Developmental dysplasia of the hip is managed with Pavlik harness treatment in infants and with surgical reduction, pelvic and femoral osteotomies, and acetabular reconstruction for older children with residual dysplasia. Perthes disease and slipped capital femoral epiphysis are managed with observation, bracing, and surgical pinning or osteotomy according to age, severity, and imaging findings. Clubfoot treatment using the Ponseti method achieves correction in over 95% of cases with a series of casting followed by percutaneous Achilles tenotomy and bracing. Limb lengthening and deformity correction using circular external fixation (Taylor Spatial Frame) or intramedullary nailing addresses limb length discrepancy and angular deformities from any cause — growth disturbance, congenital anomaly, or post-traumatic. Paediatric fracture care, including growth plate fracture management that minimises the risk of physeal arrest, and management of acute and chronic bone infections (osteomyelitis and septic arthritis), complete our paediatric orthopaedic offering. Metabolic bone disease, osteogenesis imperfecta, skeletal dysplasias, and neuromuscular conditions such as cerebral palsy and Duchenne muscular dystrophy — all of which have significant orthopaedic manifestations — are managed in close collaboration with paediatric neurology, endocrinology, and genetics. Our multidisciplinary paediatric orthopaedic MDT reviews complex cases weekly, ensuring that surgical planning integrates all relevant medical and developmental considerations. Families are supported by our specialist nurses and physiotherapists throughout every stage of treatment.
Explore →Sports Medicine & Orthopaedic Rehabilitation
The Sports Medicine & Orthopaedic Rehabilitation Centre at SilverOak Health serves athletes and active individuals at every level — from recreational exercisers to elite professionals — providing rapid, accurate diagnosis, evidence-based treatment, and targeted rehabilitation to enable safe, timely return to sport and activity. Our sports medicine physicians, orthopaedic surgeons, physiotherapists, strength and conditioning coaches, and sports dietitians collaborate as an integrated team. Non-operative sports medicine services encompass musculoskeletal ultrasound assessment and imaging-guided procedures — including corticosteroid, platelet-rich plasma, and hyaluronic acid injections — for tendinopathies, ligament injuries, bursitis, and osteoarthritis. Biomechanical analysis using motion capture and force plate technology identifies movement dysfunction contributing to injury risk. Concussion management follows SCAT5 protocols with graduated return-to-play under medical supervision. Sports cardiology provides pre-participation cardiovascular screening and ECG interpretation for competitive athletes. Surgical sports medicine is delivered arthroscopically through small portals. ACL reconstruction using autograft tissue with anatomical tunnel placement and criteria-based return-to-sport testing achieves re-rupture rates below published benchmarks. Meniscal repair — preferred over partial meniscectomy wherever biologically feasible — preserves meniscal function and reduces long-term osteoarthritis risk. Shoulder stabilisation for instability, rotator cuff repair, SLAP lesion management, and hip arthroscopy for femoroacetabular impingement complete our arthroscopic portfolio. Cartilage defect treatment using microfracture, autologous chondrocyte implantation, osteochondral autograft (OATS), and matrix-assisted autologous chondrocyte implantation offers options for patients with focal chondral defects who wish to preserve their natural joint and delay or avoid joint replacement. Platelet-rich plasma and bone marrow aspirate concentrate injections are offered for biologically active patients with early-to-moderate arthritis seeking to delay surgical intervention. Our rehabilitation programme follows validated criteria-based, not time-based, return-to-sport protocols, ensuring athletes demonstrate objective evidence of limb symmetry in strength, power, and neuromuscular control before resuming full competition. Injury prevention programmes using FIFA 11+, neuromuscular training, and load management education are offered to teams and individual athletes to reduce primary and recurrent injury risk. Our performance rehabilitation team works with athletes throughout the recovery continuum — from acute injury management through full competitive return.
Explore →Joint Replacement Centre
The Joint Replacement Centre at SilverOak Health is a high-volume, dedicated programme for primary and revision arthroplasty of the knee, hip, shoulder, and ankle, combining robotic-arm assisted surgical precision with evidence-based enhanced recovery pathways to deliver consistent, excellent functional outcomes for patients with end-stage joint arthritis and other joint-destructive conditions. Robotic-arm assisted total knee replacement using the Mako SmartRobotics platform is the standard of care in our programme. Pre-operative CT-based three-dimensional planning creates a patient-specific virtual surgical model, and intraoperative haptic resistance ensures every bone cut matches the plan with sub-millimetre accuracy. This precision translates into superior implant alignment, more natural knee kinematics, and potentially longer implant survivorship compared to conventional instrumented techniques. Total hip arthroplasty employs robotic assistance and computer navigation to achieve precise cup inclination and anteversion, leg length restoration, and femoral offset — the key determinants of hip biomechanics, stability, and long-term function. Cementless press-fit implant fixation with biological bone ingrowth is standard for most patients under 75; cemented fixation is used for those with poor bone quality. The direct anterior approach — through a muscle-sparing interval — reduces recovery time and allows early unrestricted mobilisation. Enhanced recovery protocols encompass preoperative patient optimisation and education, spinal anaesthesia, multimodal analgesia minimising opioid requirements, same-day surgery mobilisation with physiotherapy, and discharge planning from the day of admission. Most patients are walking within hours of surgery and go home within two days. Post-discharge physiotherapy — including both outpatient and home-based programmes — is structured to achieve full functional independence within six to twelve weeks. Revision joint replacement for failed primary implants — requiring removal of well-fixed components, addressing bone deficiency, and restoring biomechanics — is among the most technically demanding procedures in orthopaedic surgery and is performed by our most experienced revision surgeons. Our joint replacement outcomes including implant survivorship, Oxford Knee and Hip Scores, complication rates, and readmission rates are reported to national joint registries, enabling transparent benchmarking and continuous quality improvement.
Explore →Gynaecological Cancer Centre
The Gynaecological Cancer Centre at SilverOak Health provides specialist, multidisciplinary care for cancers of the cervix, uterus, ovary, vulva, and vagina within a fully integrated programme encompassing surgical oncology, medical oncology, and radiation oncology. Our gynaecological oncologists, medical oncologists, radiation oncologists, and specialist nurses collaborate at weekly gynaecological tumour board meetings to ensure personalised, evidence-based treatment planning for every patient. Endometrial cancer — the most common gynaecological malignancy — is treated with robotic-assisted total hysterectomy, bilateral salpingo-oophorectomy, and sentinel lymph node mapping using indocyanine green fluorescence for staging. Molecular classification into POLE-mutated, MSI-high, copy-number high, and copy-number low subgroups guides adjuvant therapy selection, with immune checkpoint inhibition now incorporated into first-line advanced disease management for MSI-high tumours. Cervical cancer management encompasses radical hysterectomy with pelvic lymphadenectomy for early-stage disease — performed robotically to minimise blood loss and enable faster recovery — and concurrent chemoradiotherapy with cisplatin for locally advanced disease. Sentinel lymph node biopsy with ultrastaging offers a minimally invasive approach to nodal assessment for early cervical cancer. Brachytherapy — intracavitary and interstitial — is integral to the definitive radiation treatment of cervical cancer, delivered with MRI-guided adaptive planning. Ovarian cancer surgery aims for complete macroscopic cytoreduction — removal of all visible disease — which is the most powerful prognostic factor for survival. Our gynaecological oncologists perform ultra-radical surgery including bowel resection, diaphragm stripping, splenectomy, and liver surface resection when required to achieve complete cytoreduction. PARP inhibitors — olaparib, niraparib, and rucaparib — are used as maintenance therapy in BRCA-mutated and HRD-positive tumours, dramatically extending progression-free survival. Fertility-sparing surgery — trachelectomy for cervical cancer and conservative surgical staging for selected endometrial and ovarian cancers — is offered to young women wishing to preserve reproductive capacity when oncologically safe. Vulvar cancer surgery employs sentinel lymph node biopsy to minimise groin morbidity while maintaining accurate nodal staging. Our survivorship programme addresses the sexual health, hormonal, and psychological consequences of gynaecological cancer treatment, supported by specialist nurses, psychosexual therapists, and menopause specialists.
Explore →Paediatric Oncology & BMT Centre
The Paediatric Oncology & BMT Centre at SilverOak Health provides comprehensive, family-centred cancer care for children and adolescents, managing leukaemias, lymphomas, brain tumours, solid tumours, and histiocytic disorders within a multidisciplinary programme that encompasses medical oncology, surgical oncology, radiation oncology, and bone marrow transplantation. Our paediatric oncologists, specialist nurses, psychologists, play therapists, and teachers deliver care that addresses the physical, emotional, educational, and developmental needs of every child and their family. Acute lymphoblastic leukaemia — the most common childhood cancer — is treated with risk-stratified Berlin-Frankfurt-Münster (BFM)-based protocols achieving cure rates exceeding 85% in standard-risk disease. Acute myeloid leukaemia, chronic myeloid leukaemia, and myelodysplastic syndrome are managed with age-appropriate intensive regimens and allogeneic BMT for high-risk cases. Comprehensive molecular diagnostics including cytogenetics, FISH, and next-generation sequencing characterise each leukaemia's risk profile and identify actionable targets. Paediatric solid tumours managed at our centre include Wilms tumour, neuroblastoma, rhabdomyosarcoma, Ewing sarcoma, osteosarcoma, hepatoblastoma, and retinoblastoma. Multidisciplinary management integrating neoadjuvant chemotherapy, organ-preserving surgery, and radiation therapy — planned in dedicated paediatric tumour boards — consistently achieves outcomes aligned with Children's Oncology Group benchmarks. Limb-salvage surgery for bone tumours uses expandable endoprostheses in growing children, preserving function throughout skeletal maturation. Haematopoietic stem cell transplantation — autologous for selected solid tumours and allogeneic for haematological malignancies and non-malignant conditions including aplastic anaemia, immune deficiencies, and metabolic storage disorders — is performed within our dedicated paediatric transplant unit. Matched sibling, matched unrelated donor, haploidentical, and umbilical cord blood transplants are all offered, with GVHD prevention strategies and infection surveillance protocols adapted to each donor source and patient age. Late effects monitoring — addressing cardiac, endocrine, neurocognitive, reproductive, and growth-related consequences of cancer treatment — is provided through our structured survivorship programme, recognising that the consequences of treatment may not manifest until years after therapy completion. Psychosocial support for children, siblings, and parents throughout the cancer journey — including play therapy, art therapy, school liaison, and bereavement support — is integral to our approach. Our return-to-school programme ensures educational continuity during and after treatment.
Explore →Prostate & Urological Cancer Centre
The Prostate & Urological Cancer Centre at SilverOak Health provides specialist, multidisciplinary care for cancers of the prostate, kidney, bladder, testis, upper urinary tract, and penis. Our team of urological oncologists, medical oncologists, and radiation oncologists collaborates within a dedicated urological cancer MDT, ensuring every patient receives an evidence-based, personalised treatment plan that considers both oncological outcomes and functional preservation. Prostate cancer management encompasses active surveillance for low-risk disease, robotic-assisted radical prostatectomy for localised cancer, stereotactic body radiotherapy and low/high-dose-rate brachytherapy for radiation candidates, and hormone therapy with novel antiandrogens — enzalutamide, apalutamide, darolutamide — and abiraterone for advanced and metastatic disease. PSMA PET-CT for biochemical recurrence detection and molecular targeting, and lutetium-PSMA radioligand therapy for metastatic castration-resistant prostate cancer, represent the most advanced systemic options in our programme. Kidney cancer surgery employs robotic-assisted partial nephrectomy — maximising nephron preservation while achieving complete tumour excision — and radical nephrectomy for large or complex tumours. Thermal ablation (radiofrequency and cryoablation) guided by CT or ultrasound is offered for small renal masses in patients unsuitable for surgery. Targeted therapies (sunitinib, pazopanib, cabozantinib) and immune checkpoint inhibition combinations (nivolumab plus ipilimumab, pembrolizumab plus axitinib) define the landscape of medical treatment for advanced renal cell carcinoma. Bladder cancer management includes endoscopic transurethral resection, intravesical BCG and chemotherapy for non-muscle-invasive disease, and robotic-assisted radical cystectomy with ileal conduit or orthotopic neobladder construction for muscle-invasive and high-risk non-muscle-invasive disease. Enhanced imaging including blue-light cystoscopy and narrow-band imaging improves detection of flat, high-grade lesions at surveillance cystoscopy. Testicular cancer surgery, retroperitoneal lymph node dissection, and platinum-based chemotherapy achieve cure rates exceeding 95% for most testicular cancer presentations. Upper tract urothelial carcinoma is managed by ureteroscopic biopsy and ablation for low-risk lesions, and nephroureterectomy for high-grade disease. Our urooncology specialist nurses support patients through treatment, managing catheter care, ostomy education, sexual function counselling, and long-term surveillance follow-up. Patient outcomes including margin rates, continence recovery, complication rates, and cancer-specific survival are prospectively collected and submitted to national urological cancer databases.
Explore →Gastrointestinal Cancer Centre
The Gastrointestinal Cancer Centre at SilverOak Health provides comprehensive care for cancers of the oesophagus, stomach, liver, pancreas, biliary tract, small intestine, colon, rectum, and anus within a fully integrated multidisciplinary programme. Our GI oncology team — comprising surgical oncologists, medical oncologists, radiation oncologists, hepatobiliary surgeons, gastroenterologists, and radiologists — meets at weekly GI tumour board meetings to plan personalised treatment for every patient. Colorectal cancer surgery is performed using robotic-assisted and laparoscopic techniques — right and left hemicolectomy, anterior resection, abdominoperineal resection, and total mesorectal excision — achieving complete oncological clearance with reduced morbidity and faster recovery compared to open surgery. Transanal minimally invasive surgery (TAMIS) and transanal total mesorectal excision (TaTME) are available for select rectal cancers. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is offered for peritoneal surface malignancies in selected patients. Upper GI oncology encompasses oesophagectomy (Ivor Lewis and three-stage approaches), total and subtotal gastrectomy with D2 lymphadenectomy, and pancreaticoduodenectomy (Whipple procedure) and distal pancreatectomy for pancreatic and periampullary cancers. Hepatectomy for primary hepatocellular carcinoma and colorectal liver metastases, cholecystectomy for gallbladder cancer, and bile duct resection for cholangiocarcinoma are performed by our specialist hepatobiliary surgeons. Neoadjuvant chemoradiotherapy and perioperative chemotherapy are used to downstage resectable and borderline-resectable tumours. Endoscopic oncology services include endoscopic mucosal resection and submucosal dissection for early oesophageal and gastric cancers, polypectomy and endoscopic treatment of early colorectal lesions, biliary stenting for obstructive jaundice, and EUS-guided sampling and ablation. ERCP for biliary access, cholangioscopy for bile duct lesion evaluation, and palliation of malignant gastric outlet obstruction with enteral stenting are provided by our advanced endoscopy team. Systemic therapy for GI cancers includes fluoropyrimidine-based chemotherapy, targeted agents such as anti-EGFR antibodies for RAS wild-type colorectal cancer, anti-VEGF therapy, HER2-targeted treatment for gastric and oesophageal adenocarcinoma, FOLFOX-based regimens for hepatocellular carcinoma, and immune checkpoint inhibition for MSI-high and dMMR tumours across multiple GI cancer types. Nutritional support, including perioperative enhanced recovery, is integral to our programme.
Explore →Lung Cancer & Thoracic Oncology Centre
The Lung Cancer & Thoracic Oncology Centre at SilverOak Health provides expert multidisciplinary management of lung cancer, mesothelioma, thymoma, and other thoracic malignancies. Our team of thoracic oncologists, thoracic surgeons, radiation oncologists, interventional pulmonologists, and oncology specialist nurses meets at weekly thoracic tumour boards to ensure every patient receives an evidence-based, personalised treatment plan from the moment of diagnosis. Comprehensive molecular profiling of all non-squamous and selected squamous non-small cell lung cancers identifies EGFR, ALK, ROS1, KRAS G12C, BRAF, MET exon 14, RET, and NTRK driver alterations that direct targeted therapy selection. PD-L1 expression and tumour mutational burden guide immunotherapy eligibility. Liquid biopsy using circulating tumour DNA enables real-time monitoring of treatment response, early resistance detection, and identification of acquired resistance mechanisms that guide subsequent treatment sequencing. Thoracic surgery for early-stage lung cancer employs video-assisted and robotic-assisted thoracoscopic lobectomy, segmentectomy, and sub-lobar resection through minimally invasive approaches, achieving equivalent oncological outcomes to open thoracotomy with significantly reduced morbidity, shorter hospital stay, and faster functional recovery. Pre-operative physiological assessment and post-operative respiratory rehabilitation optimise outcomes in patients with limited pulmonary reserve. Stereotactic body radiotherapy using CyberKnife or SABR delivers ablative doses to early-stage lung tumours and oligometastatic disease with sub-millimetre precision, achieving local control rates equivalent to surgery in inoperable patients. Concurrent chemoradiotherapy for locally advanced unresectable disease is delivered according to the latest protocols, with durvalumab consolidation immunotherapy for eligible patients improving overall survival. Endobronchial ultrasound-guided mediastinal staging, electromagnetic navigation bronchoscopy for peripheral lesion biopsy, bronchoscopic tumour ablation, and endobronchial valve placement for emphysema are performed by our interventional pulmonology team. Palliative and supportive care, integrated from the point of diagnosis, ensures symptom management, psychological support, and quality-of-life optimisation alongside active cancer treatment throughout the disease course.
Explore →Blood Cancer & Bone Marrow Transplant Centre
The Blood Cancer & Bone Marrow Transplant Centre at SilverOak Health provides expert diagnosis and treatment of the full spectrum of haematological malignancies — leukaemia, lymphoma, myeloma, myeloproliferative neoplasms, and myelodysplastic syndromes — within a comprehensive, accredited programme that includes autologous and allogeneic haematopoietic stem cell transplantation and CAR-T cell therapy. Diagnostic haematology services include bone marrow aspiration and trephine biopsy with morphological, flow cytometric, cytogenetic, and molecular analysis enabling accurate WHO classification of every haematological malignancy. Minimal residual disease testing by highly sensitive molecular or flow cytometric methods guides treatment intensification and consolidation decisions in acute leukaemia and myeloma. Next-generation sequencing identifies actionable mutations — FLT3, IDH1/2, NPM1, BCR-ABL, TP53 — that direct targeted therapy selection. Treatment programmes encompass conventional and novel chemotherapy regimens, targeted agents including ibrutinib, venetoclax, ruxolitinib, azacitidine, and ivosidenib, bispecific T-cell engagers for relapsed disease, and CAR-T cell therapy within our accredited cellular therapy programme. Haematopoietic stem cell transplantation — autologous for lymphoma and myeloma, allogeneic for acute leukaemia, MDS, and aplastic anaemia — is performed within our HEPA-filtered transplant unit with comprehensive infectious disease, nutritional, and GVHD management. Our CAR-T programme is certified for commercially approved products targeting CD19 and BCMA, offering transformative treatment for patients with relapsed or refractory B-cell malignancies and multiple myeloma. The cellular therapy team manages the full pathway from leukapheresis and bridging therapy through manufacturing, infusion, and management of cytokine release syndrome and immune effector cell-associated neurotoxicity. Structured long-term follow-up monitors response durability and B-cell aplasia management. Non-malignant haematology services — encompassing anticoagulation management, bleeding disorder treatment including haemophilia and von Willebrand disease, haemolytic anaemia, immune thrombocytopenia, and transfusion medicine — complement our malignant haematology programme. Our haemostasis and thrombosis clinic provides specialist assessment for complex coagulation disorders. Multidisciplinary collaboration with infectious disease, gastroenterology, dermatology, and palliative care ensures comprehensive, integrated management for every patient throughout their haematology journey.
Explore →Breast Cancer Centre
The Breast Cancer Centre at SilverOak Health is a designated multidisciplinary cancer centre providing comprehensive, personalised care for every stage of breast cancer — from screening and early detection through active treatment, reconstruction, and survivorship. Our team of breast surgical oncologists, medical oncologists, radiation oncologists, plastic and reconstructive surgeons, radiologists, and pathologists meets weekly at a dedicated breast cancer MDT to plan individualised treatment for every new diagnosis. Diagnostic services include digital mammography, tomosynthesis, breast ultrasound, MRI for dense breasts and high-risk screening, and ultrasound or MRI-guided biopsy. Rapid assessment clinics provide same-day urgent assessment and next-day biopsy results for women with concerning breast symptoms, minimising the anxiety of diagnostic uncertainty. Germline genetic testing for BRCA1/2 and other pathogenic variants is offered to all patients meeting eligibility criteria, informing surgical decision-making and risk management for the patient and their family. Surgical options range from breast-conserving surgery (wide local excision with sentinel lymph node biopsy) for early-stage disease to skin-sparing and nipple-sparing mastectomy for larger or multifocal tumours. Oncoplastic techniques — reshaping remaining breast tissue to achieve excellent cosmetic outcomes after larger excisions — expand breast conservation eligibility. Immediate breast reconstruction using implant-based, autologous DIEP flap, or hybrid approaches is offered in close collaboration with our plastic and reconstructive surgery team. Systemic therapy — including neoadjuvant chemotherapy to downstage locally advanced disease, adjuvant chemotherapy, hormone therapy, HER2-targeted therapy, CDK4/6 inhibitors for HR-positive disease, PARP inhibitors for BRCA-mutated cancers, and immunotherapy — is planned and delivered by our breast medical oncologists. Radiation therapy following breast conservation or post-mastectomy employs advanced techniques including deep inspiration breath-hold to minimise cardiac exposure for left-sided cancers. Our breast cancer survivorship programme addresses the long-term physical and psychological effects of treatment, including lymphoedema management, menopausal symptom management, bone health, cardiac monitoring, and psychological support. Our clinical nurse specialists provide dedicated support, education, and care coordination throughout the patient's cancer journey. Patient-reported outcome measures are collected prospectively and used to drive continuous improvement in the quality and patient-centredness of our care.
Explore →Spine & Neurosurgery Centre
The Spine & Neurosurgery Centre at SilverOak Health provides surgical management of conditions affecting the brain, spinal cord, and peripheral nerves, with a particular emphasis on minimally invasive and robotic-assisted techniques that minimise surgical trauma and accelerate patient recovery. Our neurosurgeons hold dual training in cranial and spinal neurosurgical techniques, enabling a comprehensive operative capability for the full spectrum of neurological and spinal conditions. Brain tumour surgery employs neuronavigation, intraoperative MRI, 5-ALA fluorescence-guided resection, and awake craniotomy with cortical and subcortical stimulation mapping to maximise the extent of safe tumour removal while preserving neurological function. Endoscopic approaches — through natural anatomical corridors including the nasal cavity for pituitary tumours and transsphenoidal routes — avoid brain retraction and provide excellent exposure with minimal surgical footprint. Vascular neurosurgery addresses intracranial aneurysms by microsurgical clipping, AVM resection, and EC-IC bypass for complex occlusive cerebrovascular disease. Spine surgery at our centre covers the full spectrum from cervical to sacral spine. Minimally invasive techniques — tubular microdiscectomy, percutaneous pedicle screw fixation, lateral lumbar interbody fusion, and endoscopic spine surgery — are standard for appropriate cases, reducing muscle damage, blood loss, post-operative pain, and hospital stay. Navigation-assisted and robotic-guided implant placement ensures sub-millimetre accuracy for complex fusion procedures and revision surgery. Complex spinal deformity correction for adult scoliosis, kyphosis, and flatback syndrome is performed with intraoperative neurophysiology monitoring and staged planning to minimise neurological and systemic complications. Spinal cord tumour surgery — including intradural-extramedullary and intramedullary lesions — uses intraoperative neuromonitoring and ultrasonic aspiration for safe resection. Chiari malformation decompression, tethered cord release, and syrinx management complete our spinal neurosurgery repertoire. Our neuro-oncology MDT meets weekly to integrate neurosurgical, radiation oncological, and medical oncological management for every brain and spinal tumour patient. The spine MDT brings together neurosurgeons, neurologists, pain physicians, and physiotherapists to ensure that surgery is recommended only when all conservative options have been appropriately explored. Our surgical outcomes — including perioperative complication rates, neurological preservation, and functional recovery scores — are prospectively collected and audited annually.
Explore →Movement Disorders & Parkinson's Centre
The Movement Disorders & Parkinson's Centre at SilverOak Health provides dedicated, multidisciplinary care for patients with Parkinson's disease, essential tremor, dystonia, Huntington's disease, ataxias, and other movement disorders. Our movement disorder neurologists, specialist Parkinson's nurses, physiotherapists, occupational therapists, and speech-language pathologists work within an integrated team to optimise every aspect of function, independence, and quality of life for our patients. Diagnosis of movement disorders is grounded in detailed clinical assessment, supplemented by DaTSCAN functional neuroimaging to confirm dopaminergic deficit, MRI brain with specific movement disorder protocols, neuropsychological evaluation, and — when relevant — genetic testing for familial Parkinson's disease, dystonia genes, or Huntington's. Accurate diagnosis is critical because treatment strategies differ significantly between parkinsonian syndromes, tremor disorders, and atypical parkinsonism such as MSA and PSP. Medical management of Parkinson's disease employs the full range of dopaminergic therapies — levodopa, dopamine agonists, MAO-B inhibitors, and COMT inhibitors — optimised to minimise motor fluctuations and dyskinesias while maximising on-time. For advanced Parkinson's disease with refractory motor fluctuations, we offer device-aided therapies including subcutaneous apomorphine infusion, duodenal levodopa-carbidopa intestinal gel (Duodopa), and deep brain stimulation surgery. Deep brain stimulation at our centre is performed with the patient awake under local anaesthesia, enabling real-time neurological assessment during microelectrode recording and lead placement to optimise targeting accuracy within the subthalamic nucleus, globus pallidus internus, or thalamus. Post-implantation programming by our specialist DBS neurologist optimises stimulation parameters at one, three, and six months, with annual reviews thereafter. Rechargeable implantable pulse generators with battery lives up to 25 years reduce the frequency of battery replacement procedures. A comprehensive allied health programme — addressing gait and balance rehabilitation, falls prevention, LSVT BIG physiotherapy, LSVT LOUD speech therapy, and occupational therapy for fine motor and activities of daily living — is provided through individual and group formats. Neuropsychiatric aspects of movement disorders including depression, anxiety, impulse control disorders, and cognitive decline are managed within our programme with input from liaison psychiatry and clinical neuropsychology. Our annual movement disorders symposium brings patients, carers, and clinicians together to share advances in care and research.
Explore →Epilepsy & Functional Neurosurgery Centre
The Epilepsy & Functional Neurosurgery Centre at SilverOak Health is a Level 4 comprehensive epilepsy programme providing the most advanced evaluation and surgical treatment available for patients with drug-resistant epilepsy. Despite the proven effectiveness of epilepsy surgery, it remains significantly underutilised — our programme is committed to timely identification and referral of surgical candidates, reducing the years of unnecessary medication burden that many patients endure before reaching evaluation. Presurgical evaluation integrates prolonged video-EEG monitoring in our dedicated epilepsy monitoring unit, high-resolution epilepsy-protocol MRI, FDG-PET and ictal SPECT imaging, comprehensive neuropsychological assessment, and — for patients without a clear MRI lesion — stereo-EEG with intracranially implanted depth electrodes providing three-dimensional mapping of the seizure onset zone and propagation network. This non-invasive and invasive diagnostic pathway identifies surgical candidates across the full spectrum of epilepsy syndromes. Surgical interventions include resective surgery — anterior temporal lobectomy for mesial temporal sclerosis (achieving seizure freedom in over 70% at two years), extratemporal focal cortical resection, and lesionectomy for focal cortical dysplasia and cavernomas. Laser interstitial thermal therapy offers a minimally invasive ablative option for deep or eloquent-region foci, performed under MRI guidance with real-time temperature monitoring. Corpus callosotomy for refractory atonic drop attacks significantly reduces fall-related injuries in this challenging population. Deep brain stimulation of the anterior thalamic nucleus is offered as neuromodulation therapy for patients whose seizures cannot be adequately controlled by resective surgery. Vagal nerve stimulation and responsive neurostimulation — a closed-loop device that detects electrographic seizure activity and delivers responsive stimulation — complete our neuromodulation portfolio for non-resection candidates. Neuropsychological assessment before and after surgery guides counselling regarding cognitive risks and post-operative functional outcomes. Functional neurosurgery beyond epilepsy encompasses movement disorder surgery — including deep brain stimulation for Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder — and spasticity management. Our functional neurosurgery MDT meets weekly, reviewing every patient's diagnostic evaluation and surgical plan with neurosurgeons, neurologists, neuropsychologists, and neuroradiologists to ensure that operative intervention is recommended only when the evidence clearly supports patient benefit.
Explore →Comprehensive Stroke & Cerebrovascular Centre
The Comprehensive Stroke & Cerebrovascular Centre at SilverOak Health is a Joint Commission-designated comprehensive stroke centre, delivering hyper-acute stroke intervention, acute stroke unit care, and secondary stroke prevention within a fully integrated, multidisciplinary programme. Our vascular neurologists, interventional neuroradiologists, stroke nurses, and rehabilitation therapists work together in a model proven to reduce stroke-related mortality and disability by 20–30% compared to general medical ward care. Hyper-acute management begins with rapid clinical assessment and CT/CT angiography within 15 minutes of arrival. Intravenous thrombolysis with alteplase is administered within 30 minutes for eligible patients, and mechanical thrombectomy for large vessel occlusion is initiated within 60 minutes of arrival — door-to-reperfusion times consistently among the best in the region. Our interventional team achieves successful recanalization in over 85% of thrombectomy procedures using modern aspiration catheters and stent retrievers, maximising neurological recovery. Stroke rehabilitation commences within 24 hours of admission and is delivered using a goal-oriented, high-intensity model with a minimum of 45 minutes each of physiotherapy, occupational therapy, and speech therapy daily. Early supported discharge with community stroke team follow-up enables continuation of intensive rehabilitation at home. Our post-stroke prevention clinic addresses atrial fibrillation, hypertension, diabetes, dyslipidaemia, and carotid stenosis with interventions that reduce recurrent stroke risk by more than 50%. Cerebrovascular surgery at our centre — performed by specialist neurovascular surgeons — addresses intracranial aneurysms by microsurgical clipping, arteriovenous malformation resection, cavernoma surgery, and extracranial-intracranial bypass for complex occlusive disease. Endovascular coiling, flow diversion, and intracranial angioplasty and stenting are performed by our interventional neuroradiology team for lesions better suited to catheter-based approaches. Every cerebrovascular case is reviewed in our weekly neurovascular MDT. Carotid endarterectomy for symptomatic and asymptomatic significant carotid stenosis, carotid artery stenting as an alternative for high-risk surgical patients, and management of cerebral venous sinus thrombosis complete our cerebrovascular service. Our outcomes data — including 90-day modified Rankin scale scores, symptomatic intracranial haemorrhage rates, and door-to-needle and door-to-groin times — are submitted to national stroke audit programmes, enabling transparent benchmarking and continuous quality improvement.
Explore →Cardiac Electrophysiology & Arrhythmia Centre
The Cardiac Electrophysiology & Arrhythmia Centre at SilverOak Health is a subspecialty programme dedicated to the diagnosis and treatment of abnormal heart rhythms using catheter-based ablation and cardiac implantable device therapies. Our electrophysiologists hold subspecialty training in complex ablation techniques, three-dimensional electroanatomical mapping, and the full range of device therapies for bradyarrhythmias, tachyarrhythmias, and sudden cardiac death prevention. Catheter ablation is our most impactful therapeutic offering. Pulmonary vein isolation for atrial fibrillation — using radiofrequency, cryoablation, or pulsed field ablation technology — restores normal sinus rhythm in the majority of patients with symptomatic AF, reducing symptoms and potentially obviating long-term anticoagulation in selected cases. High-density three-dimensional mapping using contemporary electroanatomical systems enables precise delineation of complex arrhythmia substrates for persistent AF, atrial flutter, and ventricular tachycardia, guiding targeted ablation lesion delivery. For supraventricular tachycardias, accessory pathway ablation in Wolff-Parkinson-White syndrome, and atrioventricular nodal re-entrant tachycardia, our ablation success rates exceed 97% at initial procedure. Ventricular tachycardia ablation — including epicardial access for scar-mediated VT and idiopathic VT originating from the outflow tracts — is performed by our most experienced electrophysiologists in close collaboration with cardiac intensivists trained in haemodynamic support. Device therapy services encompass the full range of implantable cardiac devices. Single, dual, and triple-chamber pacemakers, conventional and subcutaneous ICDs, leadless pacemakers entirely implanted within the right ventricle, and cardiac resynchronisation therapy devices are all implanted and managed by our device team. Remote monitoring platforms receive daily device transmissions and generate automatic alerts for actionable arrhythmias, device abnormalities, or fluid status changes, enabling proactive management between clinic visits. Wearable cardiac monitoring, Holter analysis, implantable loop recorder implantation and interrogation, tilt table testing, electrophysiology study for unexplained syncope, and genetic counselling for channelopathies and inherited arrhythmia syndromes including long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic VT complete our comprehensive arrhythmia service. Our programme outcomes including ablation success, complication rates, and device-related infection rates are prospectively collected and submitted to national and international registries.
Explore →Interventional Cardiology & Structural Heart Centre
The Interventional Cardiology & Structural Heart Centre at SilverOak Health specialises in catheter-based diagnosis and treatment of coronary artery disease, valvular heart disease, and congenital heart defects, offering minimally invasive alternatives to open cardiac surgery for an expanding range of conditions. Our catheterisation laboratories are equipped with the latest biplane fluoroscopy, intravascular imaging, and haemodynamic monitoring technology, supporting both elective and emergency interventional procedures around the clock. Coronary interventions encompass diagnostic angiography, percutaneous coronary intervention with drug-eluting stent implantation, rotational atherectomy for severely calcified lesions, and physiological assessment with FFR and iFR to guide the decision to intervene in intermediate coronary stenoses. Intravascular imaging using OCT and IVUS optimises stent sizing, positioning, and expansion, reducing the risk of stent thrombosis and restenosis. Our primary PCI programme for STEMI maintains door-to-balloon times within 60 minutes, significantly reducing infarct size and improving outcomes for the most time-critical cardiac emergencies. Structural heart interventions represent the most dynamic area of growth in our programme. Transcatheter aortic valve replacement (TAVR) for severe aortic stenosis is performed via transfemoral access under local anaesthesia and light sedation, with most patients discharged within two to three days. MitraClip edge-to-edge repair for functional and degenerative mitral regurgitation, left atrial appendage occlusion for stroke prevention in atrial fibrillation patients unsuitable for anticoagulation, and patent foramen ovale closure for cryptogenic stroke are further interventions in our structural heart portfolio. Every structural heart case is evaluated through our multidisciplinary heart team meeting, bringing together interventional cardiologists, cardiac surgeons, echocardiographers, and cardiac anaesthesiologists to ensure the most appropriate treatment is recommended for each patient. Transcatheter tricuspid valve interventions and transcatheter pulmonary valve replacement are also available for selected patients with complex valvular disease. Our structural heart programme contributes outcomes data to national registries, enabling transparent benchmarking and quality improvement. Renal denervation for resistant hypertension, transcatheter closure of paravalvular leaks after surgical valve replacement, alcohol septal ablation for hypertrophic obstructive cardiomyopathy, and management of complex coronary anatomy including chronic total occlusion revascularisation complete the breadth of our interventional cardiology offering. Our programme is supported by a dedicated catheterisation laboratory nursing team, perfusionists, and cardiac anaesthesiologists with subspecialty interventional experience.
Explore →Heart Transplant & Advanced Heart Failure Centre
The Heart Transplant & Advanced Heart Failure Centre at SilverOak Health is a specialist programme dedicated to the management of end-stage heart failure and the evaluation and performance of cardiac transplantation. Our multidisciplinary team — comprising advanced heart failure cardiologists, cardiac transplant surgeons, specialist heart failure nurses, and transplant coordinators — provides the full continuum of care from optimised medical therapy through mechanical circulatory support and ultimately transplantation. Advanced heart failure management at our centre begins with comprehensive evaluation including right heart catheterisation, cardiopulmonary exercise testing, and cardiac imaging to characterise haemodynamic status, functional capacity, and reversibility of cardiac dysfunction. Optimised guideline-directed medical therapy — including RAAS inhibition, beta-blockade, mineralocorticoid receptor antagonism, SGLT2 inhibition, and diuresis — is titrated by our specialist team to achieve the best possible clinical status before considering escalation. For patients who deteriorate despite optimal medical therapy, our centre offers temporary mechanical circulatory support using intra-aortic balloon pumps, Impella micro-axial ventricular assist devices, and venoarterial ECMO as bridges to recovery, decision, or transplantation. Long-term durable left ventricular assist devices provide destination therapy for transplant-ineligible patients and bridge-to-transplant support for listed candidates, significantly improving quality of life and survival in this otherwise critically ill population. Cardiac transplantation evaluation follows rigorous multidisciplinary criteria encompassing haemodynamic and functional assessments, psychosocial evaluation, comorbidity screening, and immunological workup. Our transplant team maintains close liaison with national organ allocation networks to minimise waiting times for listed candidates. The surgical procedure itself employs bicaval anastomosis techniques that preserve sinus node function and reduce the need for permanent pacing after transplantation. Post-transplant immunosuppression management, surveillance endomyocardial biopsies, rejection treatment, and long-term monitoring for allograft vasculopathy, malignancy, renal dysfunction, and infection are provided by our dedicated transplant follow-up clinic. Our one-year and five-year post-transplant survival rates are consistently at or above national registry benchmarks. Patient and family support throughout the transplant journey — from listing through recovery and beyond — is provided by our transplant coordinators and specialist psychosocial team.
Explore →Cardiac Sciences
The Cardiac Sciences Centre of Excellence at SilverOak Health is one of the region's most comprehensive heart care programmes, managing thousands of cardiac cases annually across the full spectrum from preventive cardiology and outpatient management to complex interventions, cardiac surgery, and heart failure. Our team of interventional cardiologists, cardiac surgeons, electrophysiologists, and cardiac intensivists works within weekly multidisciplinary heart team meetings to ensure every patient receives the most appropriate, evidence-based treatment. Interventional cardiology services include coronary angiography and percutaneous coronary intervention with drug-eluting stents, intravascular imaging with OCT and IVUS, and physiological assessment using FFR and iFR. Our primary PCI programme for STEMI maintains door-to-balloon times consistently within 60 minutes, meeting the most stringent international targets. Structural heart interventions — TAVR for aortic stenosis, MitraClip for mitral regurgitation, and left atrial appendage occlusion — are performed by our structural heart team in a dedicated hybrid catheterisation laboratory. Cardiac surgery at our centre delivers coronary artery bypass grafting using total arterial revascularisation strategies with bilateral internal mammary arteries for superior long-term graft patency. Valve repair and replacement, combined coronary and valvular procedures, minimally invasive cardiac surgery via mini-sternotomy, and robotic-assisted procedures reduce the surgical burden while achieving excellent oncological outcomes. Off-pump CABG is available for patients with significant aortic atherosclerosis. Our electrophysiology and arrhythmia service offers catheter ablation for atrial fibrillation — including pulsed field ablation — atrial flutter, supraventricular tachycardias, and ventricular tachycardia using high-density three-dimensional electroanatomical mapping. Device therapy services encompass implantation of pacemakers, ICDs, subcutaneous ICDs, leadless pacemakers, and cardiac resynchronisation therapy devices, with remote monitoring standard for all implanted patients. Heart failure management integrates advanced pharmacological therapy, cardiac resynchronisation, and — for end-stage disease — evaluation for ventricular assist device implantation and cardiac transplantation at our advanced heart failure centre. Preventive cardiology and cardiac rehabilitation programmes focus on aggressive risk factor management and structured exercise, reducing first and recurrent cardiovascular events. Our cardiac outcomes are prospectively collected and benchmarked against national and international registry data.
Explore →Women's Health
The Women's Health Centre of Excellence at SilverOak Health provides holistic, evidence-based care across every stage of a woman's life — from adolescent gynaecology and reproductive health through pregnancy, menopause, and gynaecological oncology. Our team of obstetricians, gynaecologists, maternal-foetal medicine specialists, reproductive endocrinologists, and oncogynecologists delivers subspecialty expertise within a compassionate, patient-centred environment. Obstetric services encompass both routine and high-risk pregnancy management, including pre-eclampsia, gestational and pre-existing diabetes, cardiac disease in pregnancy, multiple pregnancies, and foetal anomalies. Our labour and delivery suite operates around the clock with experienced midwives, obstetricians, and neonatologists immediately available. Detailed foetal medicine services include first trimester combined screening, anomaly scanning, foetal echocardiography, growth and Doppler surveillance, amniocentesis, and chorionic villus sampling. Our fertility and reproductive medicine programme combines the latest assisted reproductive technology with individualised, compassionate care. IVF with ICSI, time-lapse embryo monitoring, preimplantation genetic testing for chromosomal abnormalities and monogenic disorders, and fertility preservation for medical and elective indications are all offered within our state-of-the-art embryology laboratory. Clinical pregnancy rates per transfer consistently exceed national benchmarks. Minimally invasive gynaecological surgery — including total laparoscopic hysterectomy, laparoscopic myomectomy, endometrioma surgery, and treatment of deep infiltrating endometriosis — is the standard of care for most benign surgical indications, delivering faster recovery and fewer complications than open surgery. Our endometriosis service offers subspecialty expertise in complex disease involving the bowel, bladder, and ureter within a dedicated multidisciplinary team. Gynaecological oncology services encompass surgical staging and treatment of cervical, endometrial, and ovarian cancers, using robotic-assisted approaches that achieve complete oncological clearance with reduced morbidity. Urogynaecology provides specialist assessment and both conservative and surgical management for pelvic floor disorders. Breast health services including screening mammography, diagnostic biopsy, and breast cancer surgery with immediate reconstruction complete our comprehensive women's health offering.
Explore →Neurosciences
The Neurosciences Centre of Excellence at SilverOak Health provides expert assessment and treatment for the full spectrum of neurological and neurosurgical conditions, from common presentations such as headache, epilepsy, and stroke to rare and complex neurodegenerative and neuro-oncological diseases. Our multidisciplinary team of vascular neurologists, epileptologists, movement disorder specialists, neurosurgeons, neuroradiologists, and neurorehabilitation therapists delivers seamlessly integrated care. Our 24/7 Comprehensive Stroke Unit provides hyper-acute stroke management with CT and CT angiography within 15 minutes of arrival, intravenous thrombolysis within 30 minutes for eligible patients, and mechanical thrombectomy for large vessel occlusion initiated within 60 minutes door-to-groin. Our interventional team achieves successful recanalization in over 85% of thrombectomy cases, with functional independence at 90 days significantly exceeding published benchmarks. Epilepsy services encompass a Level 4 monitoring unit with video-EEG, high-resolution MRI, PET and SPECT imaging, neuropsychological assessment, and stereo-EEG with intracranially implanted depth electrodes for presurgical evaluation. Resective surgery, laser interstitial thermal therapy, vagal nerve stimulation, and responsive neurostimulation are all offered within our established surgical programme, achieving seizure freedom rates exceeding 70% for mesial temporal sclerosis. Movement disorders and Parkinson's disease management includes deep brain stimulation surgery with intraoperative microelectrode recording, specialist DBS programming, and a comprehensive multidisciplinary rehabilitation programme. Brain tumour surgery employs neuronavigation, intraoperative MRI, 5-ALA fluorescence, and awake craniotomy with cortical mapping to maximise safe resection extent. Cerebrovascular surgery addresses aneurysms, arteriovenous malformations, and complex occlusive disease. Spine neurosurgery — covering cervical and lumbar disc surgery, spinal cord tumour resection, Chiari decompression, and complex deformity correction — is performed with intraoperative neurophysiology monitoring. Our neurorehabilitation programme — integrating physiotherapy, occupational therapy, speech-language pathology, and neuropsychology — maximises functional recovery after neurological injury. Weekly neurosciences MDT meetings ensure every complex patient receives coordinated, evidence-based care.
Explore →Nephrology & Urology
The Nephrology & Urology Centre of Excellence at SilverOak Health is a destination for the most complex kidney and urological conditions, combining the full range of renal replacement therapy, kidney transplantation, and advanced urological surgery under one integrated programme. Our consultant nephrologists, transplant surgeons, and urological surgeons bring deep subspecialty expertise supported by specialist nurses, dietitians, and transplant coordinators. Nephrology services encompass the diagnosis and management of acute and chronic kidney disease, glomerular diseases, diabetic nephropathy, hypertensive nephrosclerosis, polycystic kidney disease, and multisystem conditions affecting the kidney. Kidney biopsy under ultrasound guidance with rapid specialist pathological reporting provides histological diagnoses that guide targeted immunosuppressive or disease-specific therapy. Comprehensive CKD-mineral bone disorder and anaemia management delay disease progression and reduce end-stage complications. Our renal replacement therapy programme offers in-centre haemodialysis across three daily shifts, home haemodialysis, automated and continuous ambulatory peritoneal dialysis, and haemodiafiltration for patients who benefit from high-volume convective clearance. Pre-dialysis education enables patients approaching end-stage renal disease to make unhurried, fully informed decisions about their preferred modality. Our kidney transplant programme performs living and deceased donor transplants with one-year graft survival rates consistently exceeding 95%. Urological services at our centre cover the full spectrum of conditions affecting the urinary tract and male reproductive system. Robotic-assisted prostatectomy for prostate cancer, partial and radical nephrectomy, radical cystectomy with urinary diversion, and endoscopic management of stone disease using flexible ureteroscopy and laser lithotripsy are among our highest-volume procedures. Urological oncology outcomes including surgical margin rates, continence, and potency recovery are prospectively collected and benchmarked nationally. Functional urology services address benign prostatic hyperplasia, overactive bladder, urinary incontinence, and erectile dysfunction, with both medical and minimally invasive surgical options. Urogynaecological collaboration ensures seamless joint management of female pelvic floor disorders requiring combined expertise. Every complex case is discussed at our weekly urology MDT to ensure optimal, individualised treatment planning.
Explore →Oncology
The Oncology Centre of Excellence at SilverOak Health delivers comprehensive, multidisciplinary cancer care across the full spectrum of malignancies — from common cancers to rare and complex tumours. Our oncology team comprises medical oncologists, radiation oncologists, surgical oncologists, haematologists, and specialist nurses who collaborate within weekly tumour board meetings to develop personalised treatment plans grounded in the latest international evidence. Molecular tumour profiling using next-generation sequencing is performed for all eligible patients, identifying actionable driver mutations, predictive biomarkers such as PD-L1 expression and tumour mutational burden, and microsatellite instability status. This precision oncology approach guides selection of targeted therapies, immune checkpoint inhibitors, and antibody-drug conjugates, and determines eligibility for clinical trials that offer access to the most promising investigational agents. Our systemic anticancer therapy day unit administers chemotherapy, targeted therapy, immunotherapy, and bispecific antibody regimens in a purpose-designed environment staffed by experienced oncology nurses and clinical pharmacists. Electronic prescribing, pharmacist-led dose verification, and proactive toxicity monitoring minimise medication errors and treatment-related hospital admissions. Anti-emetic protocols, growth factor support, and comprehensive patient education are standard for all patients commencing systemic therapy. Radiation oncology employs intensity-modulated radiotherapy, stereotactic body radiotherapy, and CyberKnife stereotactic radiosurgery to deliver ablative doses with sub-millimetre precision to tumours while maximising normal tissue sparing. Robotic-assisted cancer surgery using the da Vinci system enables precise oncological resections with complete tumour clearance and superior functional preservation compared to open approaches. CAR-T cell therapy for relapsed or refractory B-cell malignancies and multiple myeloma, bone marrow transplantation for haematological malignancies, and palliative and supportive care integrated from the point of diagnosis complete our end-to-end cancer care programme. Our survivorship clinic addresses the long-term effects of treatment and supports patients in returning to full health after cancer.
Explore →Orthopedics & Sports Medicine
The Centre of Excellence in Orthopedics & Sports Medicine at SilverOak Health is a comprehensive musculoskeletal care destination, managing thousands of joint, spine, and sports injury cases annually. Our fellowship-trained orthopaedic surgeons, sports medicine physicians, and rehabilitation specialists work within a tightly coordinated team to deliver the highest standards of surgical and non-surgical care for every patient who walks through our doors. Our joint replacement programme is among the most advanced in the region, employing robotic-arm assisted technology for total knee and hip arthroplasty. This precision platform uses pre-operative CT-based three-dimensional planning and intraoperative haptic feedback to achieve sub-millimetre implant positioning, ensuring optimal biomechanical alignment and maximising implant longevity. Patients benefit from enhanced recovery pathways with same-day mobilisation, and most return home within two to three days of surgery. Sports medicine services at SilverOak encompass the full spectrum of athletic injuries — from ACL and meniscal tears to rotator cuff injuries, shoulder instability, and cartilage defects. Arthroscopic techniques performed through small keyhole incisions minimise surgical trauma and accelerate recovery. Our sports medicine physicians also manage non-operative injuries with ultrasound-guided injections, platelet-rich plasma therapy, and biomechanical analysis. Spine surgery at our centre addresses degenerative disc disease, spinal stenosis, spondylolisthesis, and disc herniation using minimally invasive approaches that reduce muscle damage and hospital stay compared to open surgery. Navigation-assisted screw placement and robotic guidance ensure implant accuracy in complex fusion procedures. Spinal cord tumour surgery and complex deformity correction are performed with intraoperative neuromonitoring. Paediatric orthopaedics, hand surgery, foot and ankle surgery, and revision arthroplasty for failed implants complete our comprehensive orthopaedic offering. Our multidisciplinary team — including physiotherapists, occupational therapists, pain management physicians, and orthopaedic specialist nurses — provides seamless care from initial consultation through surgical intervention, rehabilitation, and long-term functional follow-up, consistently achieving outcomes that exceed national benchmarks.
Explore →